MedTrace Logo

National Multicenter Interventional Study Aimed at Evaluating the Effect on the Intestinal Microbiota in Chronically Frail Patients Who Share Alterations in Intestinal Function.

NCT06005506 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-08-22

No results posted yet for this study

Summary

The objective of the study will be to understand whether a supplementation of the diet with an active symbiotic, i.e. characterized by a mix of probiotics and a specially selected fiber with prebiotic activity combined with a vegetable extract with beneficial activities on carbohydrate and lipid metabolism, can reduce the relative inflammatory potential and improve absorption, intestinal motility and bowel habit of patients with various pathological conditions, such as ALS, ADHD and bronchial asthma.

Conditions

  • Adhd
  • ALS
  • Bronchial Asthma

Interventions

DIETARY_SUPPLEMENT

Prebiotic fiber

Moradyn active prebiotic fiber product

DIETARY_SUPPLEMENT

Dietary fiber

Fibregum non-active fiber product

DIETARY_SUPPLEMENT

Probiotic

Defense Plus probiotic complex

Sponsors & Collaborators

  • Fondazione Serena Onlus - Centro Clinico NeMO Milano

    collaborator OTHER

  • IRCCS Eugenio Medea

    collaborator OTHER

  • Istituto Nazionale di Ricovero e Cura per Anziani

    collaborator OTHER

  • Institute of Biomedical Technologies-National Research Council, Italy

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-10-31
Completion
2023-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06005506 on ClinicalTrials.gov